Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 25, 2000; 54 (8) Clinical/Scientific Notes

CNS demyelination from zinc toxicity?

Calin I. Prodan, Neil R. Holland
First published April 25, 2000, DOI: https://doi.org/10.1212/WNL.54.8.1705
Calin I. Prodan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil R. Holland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
CNS demyelination from zinc toxicity?
Calin I. Prodan, Neil R. Holland
Neurology Apr 2000, 54 (8) 1705-1706; DOI: 10.1212/WNL.54.8.1705

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
411

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

A 45-year-old man presented with a 4-month history of progressive fatigue, lethargy, shortness of breath on exercise, and generalized numbness with paresthesias. Initial bloodwork showed severe pancytopenia, with a hemoglobin of 4.9 g/dL, a white blood cell count of 1,000 mm−3, and a platelet count of 121,000 mm−3. Bone marrow biopsy showed aplastic anemia with ringed sideroblasts. This was subsequently attributed to zinc toxicity with associated copper deficiency. His serum zinc level was 192 μg/dL (normal, 70 to 150 μg/dL), his serum copper level was 0 μg/dL (normal, 70 to 155 μg/dL), and his serum ceruloplasmin level was 6.8 mg/dL (normal, 16.2 to 35.6 mg/dL). Blood levels of other heavy metals, including lead, mercury, and arsenic, were normal. He was transfused with 4 U of packed red blood cells, and treated with IV copper infusions. By the time of discharge his hemoglobin was 9.4 mg/dL and his systemic symptoms had resolved. No specific source for zinc poisoning was identified, despite extensive testing.

He was evaluated in our neurology clinic 5 months later because his neurologic complaints had not improved despite continued oral copper supplementation. His hemoglobin had risen to 15.8 mg/dL and his serum copper was 76 μg/dL with a ceruloplasmin level of 17.5 mg/dL. He had not experienced any marked cognitive difficulties. His paresthesias were unchanged and he also had limb clumsiness. There was no family history of neurologic diseases. His examination showed saccadic dysmetria, slow and clumsy rapid toe tapping, decreased vibratory and joint position sensitivity in the feet, brisk reflexes, extensor plantar responses, and truncal ataxia with a positive Romberg’s sign. Serum vitamin B12, methylmalonic acid, and homocysteine levels were all within normal limits. Syphilis, human T-cell lymphotrophic virus I, and HIV serologies were all negative. Serum vitamin E level was normal. Results of nerve conduction studies and needle electromyography were also normal.

Brain MRI showed multiple bilateral periventricular white matter hyperintensities on T2-weighted images, almost confluent in some areas, with extensive involvement of the corpus callosum (figure). Lesions were also present in the cerebellar peduncles (not shown). CSF studies including cell count, protein level, oligoclonal bands, myelin basic protein, immunoglobulin G index, and Venereal Disease Research Laboratory were all normal or negative. Pattern-shift visual evoked response latencies were prolonged asymmetrically bilaterally. Auditory brainstem evoked responses were normal. Serum very long-chain fatty acids and arylsulphatase A levels were normal.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure. Brain MRI. (A, B) T2-weighted axial sections show multiple periventricular areas of increased signal intensity. (C) Sagittal fluid-attenuated inversion recovery image shows involvement of the corpus callosum.

Copper and zinc are absorbed across the proximal small bowel enterocytes. A proportion remains sequestered within the enterocytes bound to the intracellular ligand metallothionein, and the remainder is released into the enterohepatic circulation. Excess zinc levels cause an upregulation of metallothionein production, which effectively decreases intestinal absorption of both copper and zinc, resulting in copper deficiency.1 Sideroblastic anemia is a rare but recognized manifestation of zinc toxicity and associated copper deficiency.1 Previous epidemiologic studies have also implicated zinc toxicity in the pathogenesis of demyelinating diseases. Schiffer and colleagues2,3 reported a cluster of cases of MS in factory workers from northern New York with abnormally high serum zinc levels. Other studies from Canada showed an increased incidence of MS in an area with an elevated concentration of various metals including zinc.4-6

Our patient developed extensive CNS demyelination in close temporal association with documented zinc toxicity with resultant copper deficiency and sideroblastic anemia. There was no clinical or laboratory evidence of an alternative inflammatory, metabolic, or infectious etiology for his neurologic syndrome. This case lends additional support to a possible role played by zinc in the pathogenesis of demyelination and the chain of events leading to MS.

Footnotes

  • Copyright © 2000 by the American Academy of Neurology

  • Received October 8, 1999.
  • Accepted December 10, 1999.

References

  1. ↵
    Fiske DN, McCoy HE, Kitchens CS. Zinc-induced sideroblastic anemia. Report of a case, review of the literature and description of the hematologic syndrome. Am J Hematol 1994;46:147–150.
    OpenUrlPubMed
  2. ↵
    Schiffer RB. Zinc and multiple sclerosis. Neurology 1994;44:1987–1988.
    OpenUrlFREE Full Text
  3. ↵
    Stein EC, Schiffer RB, Hall WJ, Young N. Multiple sclerosis and the workplace: report of an industry-based cluster. Neurology 1987;37:1672–1677.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Hader WJ, Irvine DG, Schiefer HB. A cluster-focus of multiple sclerosis at Henribourg, Saskatchewan. Can J Neurol Sci 1990;17:391–394.
    OpenUrlPubMed
  5. Irvine DG, Schiefer HB, Hader WJ. Geotoxicology of multiple sclerosis: the Henribourg, Saskatchewan, cluster focus. I. The water. Sci Total Environ 1989;84:45–59.
    OpenUrlCrossRefPubMed
  6. ↵
    Irvine DG, Schiefer HB, Hader WJ. Geotoxicology of multiple sclerosis: the Henribourg, Saskatchewan, cluster focus. II. The soil. Sci Total Environ 1988;77:175–188.
    OpenUrlPubMed
View Abstract

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 96 (9)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise